Oncternal Therapeutics, Inc. (ONCT) Margin Analysis - Discounting Cash Flows
ONCT
Oncternal Therapeutics, Inc.
ONCT (NASDAQ)

Years and Quarters

Years

Years

The number of historical years used to render the annual chart and tables.

Quarters

Quarters

The number of historical quarters used to render the quarterly chart and tables.

Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (example: Net Income Margin = Net Income / Revenue).

This analysis provides annual and quarterly sections for reporting key financial margins.

Annual Section

The annual section uses annual data to calculate margins and growth rates.

Monetary values in USD

amounts except #

LTM
Mar 12
2023
Dec 31
2022
Dec 31
2021
Dec 31
2020
Dec 31
Revenue 1.67 0.785 1.49 4.32 3.38
Revenue Growth Rate 112.4% -47.32% -65.47% 27.85% 39.18%
Cost of Revenue 18.63 29.75 0.179 0.169 12
Gross Profit -16.96 -28.97 1.31 4.15 -8.62
Gross Margin -1,018% -3,690% 87.99% 96.08% -255.6%
Operating Income -35.96 -41.71 -44.95 -31.37 -17.54
Operating Margin -2,157% -5,314% -3,017% -726.9% -519.8%
Net Income -34.58 -39.48 -43.39 -31.3 -17.21
Net Margin -2,074% -5,029% -2,912% -725.4% -509.9%

Monetary values in USD

amounts except #

LTM
Mar 12
2023
Dec 31
2022
Dec 31
2021
Dec 31
2020
Dec 31
Revenue 1.67 0.785 1.49 4.32 3.38
Cash from Operating Activities -26.63 -32.16 -36.7 -26.59 -17.5
Cash from Operating Activities Margin -1,598% -4,097% -2,463% -616.2% -518.4%
Free Cash Flow -26.63 -32.16 -36.7 -26.59 -17.5
Free Cash Flow Margin -1,598% -4,097% -2,463% -616.2% -518.4%
Depreciation and Amortization 0.329 0 -0.075 0.169 0.15
Depreciation and Amortization Margin 19.74% 0% -5.03% 3.92% 4.44%
Capital Expenditure 0 0 0 0 0
Capital Expenditure Margin 0% 0% 0% 0% 0%

Annual Chart

Monetary values in USD

Quarterly Section

The quarterly section uses quarterly data to calculate margins and growth rates.

Monetary values in USD

amounts except #

2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
2023 (Q3)
Sep 30
2023 (Q2)
Jun 30
2023 (Q1)
Mar 31
2022 (Q4)
Dec 31
2022 (Q3)
Sep 30
Revenue 0 0.801 0.569 0.297 0.179 0.106
Revenue Growth Rate -100% 40.77% 91.58% 65.92% 68.87%
Cost of Revenue 0 5.9 6.06 6.67 0.075 0.037
Gross Profit 0 -5.1 -5.49 -6.37 0.104 0.069
Gross Margin
-636.7% -964.9% -2,146% 58.1% 65.09%
Operating Income -8.68 -8.86 -8.78 -9.64 -10.39 -9.54
Operating Margin
-1,106% -1,543% -3,244% -5,804% -9,005%
Net Income -8.46 -8.56 -8.39 -9.16 -9.86 -8.97
Net Margin
-1,069% -1,474% -3,086% -5,509% -8,458%

Monetary values in USD

amounts except #

2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
2023 (Q3)
Sep 30
2023 (Q2)
Jun 30
2023 (Q1)
Mar 31
2022 (Q4)
Dec 31
2022 (Q3)
Sep 30
Revenue 0 0.801 0.569 0.297 0.179 0.106
Cash from Operating Activities -6.95 -5.82 -7.44 -6.42 -5.51 -9.26
Cash from Operating Activities Margin
-726.8% -1,307% -2,161% -3,080% -8,739%
Free Cash Flow -6.95 -5.82 -7.44 -6.42 -5.51 -9.26
Free Cash Flow Margin
-726.8% -1,307% -2,161% -3,080% -8,739%
Depreciation and Amortization 0 0 0 0.329 0.075 0.037
Depreciation and Amortization Margin
0% 0% 110.8% 41.9% 34.91%
Capital Expenditure 0 0 0 0 0 0
Capital Expenditure Margin
0% 0% 0% 0% 0%

Quarterly Chart

Monetary values in USD

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program